Back to Search
Start Over
AN IMPROVED BENEFIT-RISK PROFILE OF DUVELISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA WHO RECEIVED 2 OR MORE PRIOR THERAPIES
- Source :
- Hematological Oncology. 37:213-214
- Publication Year :
- 2019
- Publisher :
- Wiley, 2019.
Details
- ISSN :
- 02780232
- Volume :
- 37
- Database :
- OpenAIRE
- Journal :
- Hematological Oncology
- Accession number :
- edsair.doi...........ba5f647b555c18331af0d7f1d30f51e7
- Full Text :
- https://doi.org/10.1002/hon.29_2630